MedPath

SERTRALINE HYDROCHLORIDE

These highlights do not include all the information needed to use SERTRALINE HYDROCHLORIDE ORAL SOLUTION safely and effectively. See full prescribing information for SERTRALINE HYDROCHLORIDE ORAL SOLUTION. SERTRALINE HYDROCHLORIDEORAL SOLUTION, for oral useInitial U.S. Approval: 1991

Approved
Approval ID

f5da1754-2aed-4777-ad2e-593ee43e6e86

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 17, 2023

Manufacturers
FDA

ACI Healthcare USA, Inc.

DUNS: 080430318

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

SERTRALINE HYDROCHLORIDE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code71093-143
Application NumberANDA076934
Product Classification
M
Marketing Category
C73584
G
Generic Name
SERTRALINE HYDROCHLORIDE
Product Specifications
Route of AdministrationORAL
Effective DateOctober 28, 2020
FDA Product Classification

INGREDIENTS (2)

SERTRALINE HYDROCHLORIDEActive
Quantity: 20 mg in 1 mL
Code: UTI8907Y6X
Classification: ACTIM
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

SERTRALINE HYDROCHLORIDE - FDA Drug Approval Details